pizuglanstat
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2014 (NCT02246478)
Timeline
Indications
Mechanism of action
HPGDS inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tas-205
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04825431 | Phase 1 | Mar 22, 2021 | Otsuka |
| NCT04587908 | Phase 3 | Nov 30, 2020 | Otsuka |
| NCT02752048 | Phase 2 | May 1, 2016 | Otsuka |
| NCT02246478 | Phase 1 | Sep 1, 2014 | Otsuka |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Otsuka | For profit | 4 | 4 | 3 | 2014 |
1 organizations
Page 1 / 1